Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion

NCT04271332 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

16P11.2 Deletion Syndrome

Interventions

DRUG: Arbaclofen
DRUG: Placebo oral tablet

Sponsor

Clinical Research Associates, LLC